Prescription drug addiction is tied to a system of risk that keeps shifting, even as the headlines feel familiar. In 2021, nonmedical prescription opioid use among people aged 12 and up was 3.0%, yet synthetic opioids were involved in 81.2% of opioid-related overdose deaths in 2022. The gap between misuse and fatal outcomes is exactly what the statistics help clarify, from treatment shortfalls to the real scale of opioid prescriptions.
Key Takeaways
- The nonmedical prescription opioid use prevalence among people aged 12+ in the U.S. was 3.0% in 2021 (NSDUH)
- In 2019, there were 236 million outpatient visits involving an opioid prescription in the U.S. (IQVIA Drug Trends; reported in FDA/CDC analyses)
- In 2021, 12.8 million Americans received at least one prescription for opioids (CDC Morbidity and Mortality Weekly Report estimate)
- 16% of people aged 12+ in the U.S. reported misuse of prescription pain relievers at least once in their lifetime (NSDUH, 2019–2021 combined estimate)
- From 1999 to 2020, the U.S. saw a 119% increase in drug overdose death rates involving prescription opioids (CDC analysis)
- In 2021, 9.4% of adults in the U.S. who had substance use disorders also had an opioid use disorder (NSDUH)
- In 2022, 80.1% of opioid overdose deaths involved synthetic opioids (CDC)
- In 2022, 1 in 4 adults with substance use disorders received substance use treatment (NSDUH)
- In 2021, 48% of people with OUD received any treatment (including medication for opioid use disorder) in the past year (SAMHSA/NSDUH)
- A 2018 analysis estimated that opioid use disorder (including prescription-related pathways) cost the U.S. $1.02 trillion in 2017
- A JAMA Network Open study estimated prescription opioid misuse cost the U.S. $78.5 billion in 2017 (including healthcare, criminal justice, and productivity losses)
- A CDC estimate placed lifetime economic costs per opioid overdose death at $1.2 million (2013 dollars) (CDC analysis)
- In 2012, 259 million opioid prescriptions were dispensed in the U.S. (CDC data on opioid prescribing)
- In 2017, 21% of opioid prescriptions were for 7 days or less (CDC prescribing patterns analysis)
- In 2020, 6.3% of opioid prescriptions included a benzodiazepine co-prescription within 30 days (CDC; co-prescribing analysis)
In 2021, millions misused opioids and overdoses rose, yet only about half of people with OUD got treatment.
Related reading
01 · Category
Health System Impact7 stats
01
The nonmedical prescription opioid use prevalence among people aged 12+ in the U.S. was 3.0% in 2021 (NSDUH)
02
In 2019, there were 236 million outpatient visits involving an opioid prescription in the U.S. (IQVIA Drug Trends; reported in FDA/CDC analyses)
03
In 2021, 12.8 million Americans received at least one prescription for opioids (CDC Morbidity and Mortality Weekly Report estimate)
04
In 2021, 47,000 people died from opioid overdoses in the U.S. (CDC)
05
In 2021, 1 in 7 U.S. adults reported chronic pain (CDC National Center for Health Statistics; frequently cited baseline for opioid prescribing risk)
06
In 2020, 60% of opioid-related overdose deaths also involved another drug, most commonly illicitly manufactured fentanyl (CDC analysis)
07
In 2022, 16.1 million Americans had unmet need for mental health treatment; this contributes to substance use risk pathways (SAMHSA/NSDUH)
Interpretation
Health System Impact Interpretation
In 2021, 12.8 million Americans received an opioid prescription and 47,000 died from opioid overdoses, showing that even routine prescribing within the health system can translate into severe population-level harm when other contributing risks like chronic pain and polysubstance involvement are present.
02 · Category
Epidemiology4 stats
01
16% of people aged 12+ in the U.S. reported misuse of prescription pain relievers at least once in their lifetime (NSDUH, 2019–2021 combined estimate)
02
From 1999 to 2020, the U.S. saw a 119% increase in drug overdose death rates involving prescription opioids (CDC analysis)
03
In 2021, 9.4% of adults in the U.S. who had substance use disorders also had an opioid use disorder (NSDUH)
04
In 2018, 3.3 million people in the U.S. used prescription pain relievers nonmedically for the first time in their lifetime (CDC analysis)
Interpretation
Epidemiology Interpretation
From an epidemiology perspective, misuse of prescription pain relievers remains widespread with 16% of U.S. people aged 12 and older reporting lifetime misuse, while the harm has escalated sharply as overdose death rates involving prescription opioids rose 119% from 1999 to 2020.
03 · Category
Prevention & Treatment11 stats
01
In 2022, 80.1% of opioid overdose deaths involved synthetic opioids (CDC)
02
In 2022, 1 in 4 adults with substance use disorders received substance use treatment (NSDUH)
03
In 2021, 48% of people with OUD received any treatment (including medication for opioid use disorder) in the past year (SAMHSA/NSDUH)
04
In 2021, 2.5 million people in the U.S. needed substance use treatment but did not receive it (SAMHSA NSDUH; opioid-related)
05
In 2021, an estimated 2.1 million people received medication for opioid use disorder (MOUD) in the U.S. (SAMHSA)
06
In 2016, a review found naloxone distributions to prevent overdoses with an estimated 0.9 naloxone administrations per distribution (systematic review)
07
In 2017, the U.S. had approximately 2,100 opioid treatment programs (OTPs) delivering methadone (SAMHSA OTP directory statistics)
08
In 2023, there were 16,000+ DATA-waivered buprenorphine prescribers in the U.S. (SAMHSA buprenorphine prescriber data)
09
A 2020 CDC study reported that patients receiving medication for opioid use disorder had lower overdose death rates than those not receiving MOUD (systematic evidence summary)
10
A 2015 randomized trial showed buprenorphine reduced illicit opioid use compared with placebo by 51% (peer-reviewed study)
11
A 2017 systematic review found that cognitive behavioral therapy reduced opioid misuse by about 30% versus control (meta-analysis)
Interpretation
Prevention & Treatment Interpretation
For the Prevention and Treatment angle, the data show that while synthetic opioids drove 80.1% of opioid overdose deaths in 2022, only about 1 in 4 adults with substance use disorders got treatment and an estimated 2.5 million people still went without it, underscoring how expanding evidence based options like MOUD and naloxone is urgently needed.
05 · Category
Prescribing & Supply3 stats
01
In 2012, 259 million opioid prescriptions were dispensed in the U.S. (CDC data on opioid prescribing)
02
In 2017, 21% of opioid prescriptions were for 7 days or less (CDC prescribing patterns analysis)
03
In 2020, 6.3% of opioid prescriptions included a benzodiazepine co-prescription within 30 days (CDC; co-prescribing analysis)
Interpretation
Prescribing & Supply Interpretation
In the prescribing and supply landscape, the U.S. dispensed 259 million opioid prescriptions in 2012, and even as patterns shifted by 2017 with 21% lasting 7 days or less, about 6.3% of opioid prescriptions in 2020 still included a benzodiazepine co-prescription within 30 days.
More related reading
06 · Category
Prevalence1 stats
01
1 in 11 (9.1%) U.S. adults (18+) reported using prescription opioids nonmedically in the past year in 2022
Interpretation
Prevalence Interpretation
In the prevalence snapshot, 1 in 11 or 9.1% of U.S. adults aged 18 and older reported nonmedical use of prescription opioids in the past year in 2022.
07 · Category
Mortality3 stats
01
In 2022, 8.8% of people aged 12+ with a past-year opioid use problem reported injection as a primary route in the past year
02
6.8% of opioid-related overdose deaths involved any prescription opioid (i.e., prescription opioid listed on the death record)
03
81.2% of opioid-related overdose deaths in 2022 involved synthetic opioids (including illicitly manufactured fentanyl)
Interpretation
Mortality Interpretation
From a mortality perspective, synthetic opioids drove the vast majority of opioid-related overdose deaths in 2022, with 81.2% of deaths involving them, while just 6.8% involved any prescription opioid on the death record.
08 · Category
Treatment Gap2 stats
01
49.4% of people with opioid use disorder (past year) reported receiving medication for opioid use disorder in 2023
02
In 2022, 15.5% of opioid use disorder treatment facilities reported medication availability for opioid use disorder on-site
Interpretation
Treatment Gap Interpretation
The treatment gap is still large because only 49.4% of people with opioid use disorder reported receiving medication in 2023, and even in 2022 just 15.5% of treatment facilities had medication available on site.
09 · Category
Prevention & Harm Reduction2 stats
01
A 2022 systematic review of naloxone distribution found that the median time from distribution to opioid overdose was 2–3 hours in reported observational studies
02
In 2021, 8,657 naloxone doses were reported in the SAMHSA-funded Overdose Prevention, Training, and Supplies program (Across participating sites)
Interpretation
Prevention & Harm Reduction Interpretation
For Prevention and Harm Reduction efforts, the 2022 review showing naloxone leading to overdose reversal within just 2 to 3 hours in observational studies underscores how quickly these supplies can matter, and the 8,657 reported doses in 2021 through SAMHSA’s program reflect real-world reach that can save lives.
10 · Category
Cost Analysis1 stats
01
In 2021, 1.5% of all workplace disability claims were related to opioid or substance use disorders (U.S. claims-based estimate)
Interpretation
Cost Analysis Interpretation
In 2021, opioid or substance use disorders accounted for 1.5% of all workplace disability claims, underscoring that prescription drug addiction drives a measurable share of disability-related costs.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
David Sutherland. (2026, February 13). Prescription Drug Addiction Statistics. Gitnux. https://gitnux.org/prescription-drug-addiction-statistics
MLA
David Sutherland. "Prescription Drug Addiction Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/prescription-drug-addiction-statistics.
Chicago
David Sutherland. 2026. "Prescription Drug Addiction Statistics." Gitnux. https://gitnux.org/prescription-drug-addiction-statistics.
Sources & references
42 datasets cited across this report · attribution is report-level
+32 additional datasets cited (not shown individually)